Are Ivermectin Prices Fueling Affordability Anxiety in U.S. Healthcare?
In 2025, ivermectin affordability crisis healthcare 2025 has become a major topic in U.S. healthcare discussions. Once a low-cost, widely available drug, ivermectin has seen significant price hikes, affecting households, insurance dynamics, and political debates. Rising drug costs have left Americans anxious about accessing essential treatments, sparking conversations about systemic reform, alternative medicines, and online…